Track insider transactions across markets
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | 1% | 8.2% | 15.1% |
| Success rate | 70% | 68% | 82% |
| Transactions |
7
100% Buy
|
34
71% Buy
|
47
69% Buy
|
| Position | Company | Period |
|---|---|---|
| Chairman of the Supervisory Board | Vivoryon Therapeutics AG | Jan. 22, 2013 - |
| Independent Director | Aptose Biosciences Inc | Dec. 15, 2014 - |
Search